Vascular embolization refers to the deliberate blocking or plugging of blood vessels. It is a minimally invasive procedure that is typically performed to treat medical conditions associated with blood vessels. Some key applications of vascular embolization include the management of aneurysms, uterine fibroids, tumors, and vascular malformations. There has been a significant rise in the demand for advanced interventional techniques in diagnostic and therapeutic centers.
The global Vascular Embolization Market is estimated to be valued at Us$ 1809.45 Mn in 2023 and is expected to exhibit a CAGR Of 11% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased demand from diagnostic and therapeutic centers has significantly contributed towards the accelerated growth of the vascular embolization market over the forecast period. The rising preference for minimally invasive procedures and growing preference for interventional radiology techniques have boosted the installations of angiography systems, embolization materials, and vascular embolization devices in healthcare facilities. Technological advancements in embolization devices and materials have further expanded the scope of clinical applications thereby augmenting the market growth.
Segment Analysis
The global vascular embolization market is segmented based on product, procedure, application, end user and region. Based on product, the market is segmented into embolization coils, liquid embolic agents, embolic plug systems and accessories. The embolization coils segment dominates the market and accounts for the largest market share. This is due to wide applications and usage of coils for permanent vascular occlusion during embolization procedures.
Key Takeaways
The Global Vascular Embolization Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. The global Vascular embolization Market is estimated to be valued at US$ 1809.45 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.
Regional analysis shows that North America region currently dominates the market and is expected to continue its dominance. This is due to advanced medical infrastructure and availability of technologically advanced embolization devices in countries like the US and Canada. Asia Pacific region is expected to witness fastest growth during the forecast period. This is owing to growing medical tourism industry, rising healthcare expenditure and improving medical facilities in emerging countries of China and India.
Key players related content shows that Key players operating in the vascular embolization market are DyCare, Costaisa, Meditouch, Signo Motus srl, MEYTEC GmbH Informationssysteme, and Raccoon Technologies Poland LLC. DyCare and Costaisa currently dominate the market owing to their wide product portfolio and global presence.
Get more insights on this topic :
